Publicaciones etiquetadas ‘Recursos’

Recursos

Furosemide.

Related Articles Furosemide. J Pain Symptom Manage. 2016 Jul;52(1):144-50 Authors: Carone L, Oxberry SG, Twycross R, Charlesworth S, Mihalyo M, Wilcock A Abstract Therapeutic Reviews aim to provide essential independent information for health professionals about drugs used in palliative and hospice care. Additional content is available on www.palliativedrugs.com. Country-specific books (Hospice and Palliative Care Formulary USA, and Palliative Care Formulary, British and Canadian editions) are also available and can be ordered from www.palliativedrugs.com. The series editors welcome feedback on the articles (hq@palliativedrugs.com). PMID: 27238657 [PubMed – indexed for MEDLINE]
Origen: Furosemide. – PubMed

Leer más

Recursos

Morbidity burden and community-based palliative care are associated with rates of hospital use by people with schizophrenia in the last year of life: A population-based matched cohort study.

Related Articles Morbidity burden and community-based palliative care are associated with rates of hospital use by people with schizophrenia in the last year of life: A population-based matched cohort study. PLoS One. 2018;13(11):e0208220 Authors: Spilsbury K, Rosenwax L, Brameld K, Kelly B, Arendts G Abstract OBJECTIVE: People with schizophrenia face an increased risk of premature death from chronic diseases and injury. This study describes the trajectory of acute care health service use in the last year of life for people with schizophrenia and how this varied with receipt of community-based specialist palliative care and morbidity burden. METHOD: A population-based retrospective…
Origen: Morbidity burden and community-based palliative care are associated with rates of hospital use by people with schizophrenia in the last year of life: A population-based matched cohort study. – PubMed

Leer más

Recursos

Cost-Effectiveness Analysis in Cancer Care.

Related Articles Cost-Effectiveness Analysis in Cancer Care. Cancer Treat Res. 2016;168:377-91 Authors: Chang A, Abbott DE Abstract With the increasing complexity of modern medical therapies, it is becoming imperative to recognize the marginal cost and gains of increasingly sophisticated (and expensive) interventions. By understanding the incremental cost of a given intervention, investigators must help answer questions about healthcare resource utilization that are not answered by randomized clinical trials. The continued funding of biomedical research and pharmaceuticals will require more objective study of the return on investment for any given treatment modality, and cost-effectiveness analyses will be instrumental in providing solutions…
Origen: Cost-Effectiveness Analysis in Cancer Care. – PubMed

Leer más

Recursos

Operationalizing the Measuring What Matters Spirituality Quality Metric in a Population of Hospitalized, Critically Ill Patients and Their Family Members.

Related Articles Operationalizing the Measuring What Matters Spirituality Quality Metric in a Population of Hospitalized, Critically Ill Patients and Their Family Members. J Pain Symptom Manage. 2017 Mar;53(3):650-655 Authors: Aslakson RA, Kweku J, Kinnison M, Singh S, Crowe TY, AAHPM Writing Group Abstract CONTEXT: Measuring What Matters (MWM) quality indicators support measurement of the percentage of patients who have spiritual discussions, if desired. OBJECTIVES: The objective of this study was to 1) determine the ease of, and barriers to, prospectively collecting MWM spirituality quality measure data and 2) further explore the importance of spirituality in a seriously ill, hospitalized population…
Origen: Operationalizing the Measuring What Matters Spirituality Quality Metric in a Population of Hospitalized, Critically Ill Patients and Their Family Members. – PubMed

Leer más